Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012US8193228 Substituted imidazole as bombesin receptor subtype-3 modulators
06/05/2012US8193227 HIV protease inhibiting compounds
06/05/2012US8193226 Candesartan cilexetil
06/05/2012US8193225 Isoxazole amides, derivatives and methods of chemical induction of neurogenesis
06/05/2012US8193224 Medicinal composition for prevention or treatment of parasitic protozoan infection
06/05/2012US8193223 1,2,3-triazole derivatives as sigma receptor inhibitors
06/05/2012US8193220 Method of changing muscle lengths with anesthetic drugs
06/05/2012US8193219 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
06/05/2012US8193218 Aroyl-piperidine derivatives and method of treating disorders induced by substance P
06/05/2012US8193217 Polymorphic form of granisetron hydrochloride and methods of making the same
06/05/2012US8193216 Polymorphic forms of a GABAA agonist
06/05/2012US8193214 Chymase inhibitors
06/05/2012US8193213 Spermicidal and/or antifungal composition and methods of using the same
06/05/2012US8193212 Use of huperzine for neuropathic pain
06/05/2012US8193211 Controlled release compositions of gamma-hydroxybutyrate
06/05/2012US8193210 Camptothecin derivatives with antitumor activity
06/05/2012US8193209 Analgesic combination of oxycodone and meloxicam
06/05/2012US8193208 Fused and spirocycle compounds and the use thereof
06/05/2012US8193207 Lactam compounds and methods of using the same
06/05/2012US8193206 Pyrimidine compounds
06/05/2012US8193205 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
06/05/2012US8193204 Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use
06/05/2012US8193203 Bicyclic compounds having activity at the CXCR4 receptor
06/05/2012US8193202 LIMK2 inhibitors, compositions comprising them, and methods of their use
06/05/2012US8193201 Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
06/05/2012US8193200 Antagonists of A2B adenosine receptors for treatment of inflammatory bowel disease
06/05/2012US8193199 Heterocyclic compounds and their uses
06/05/2012US8193196 Causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying under controlled conditions until reaching a settled water content in the end product; bioavailability
06/05/2012US8193195 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
06/05/2012US8193194 Ion channel modulators and methods of use
06/05/2012US8193193 Agent for prevention or treatment of glaucoma
06/05/2012US8193192 Heterocyclic FXR binding compounds
06/05/2012US8193191 Urotensin II receptor antagonists
06/05/2012US8193190 Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors
06/05/2012US8193189 Quinoxaline derivatives as tyrosine kinase activity inhibitors
06/05/2012US8193188 Methods of using pyridodihydropyrazinones
06/05/2012US8193187 1,2,3,4-tetrahydroquinoxaline compound with a phenyl group substituent having a sulfonic acid ester structure or a sulfonic acid amide structure introduced therein and having glucocorticoid receptor-binding activity
06/05/2012US8193186 Pyridopyrazines and the use thereof as kinase inhibitors
06/05/2012US8193185 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits
06/05/2012US8193184 Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use
06/05/2012US8193183 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonists
06/05/2012US8193182 Substituted isoquinolin-1(2H)-ones, and methods of use thereof
06/05/2012US8193181 Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine
06/05/2012US8193180 N-amino tetrahydrothiazine derivatives, method of manufacture and use
06/05/2012US8193179 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
06/05/2012US8193178 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor
06/05/2012US8193177 Hepatocyte growth factor pathway activators in fibrotic connective tissue diseases
06/05/2012US8193176 Phenylpyrazole derivatives
06/05/2012US8193175 Ruthenium complexes for treating cancers
06/05/2012US8193174 Responsive luminescent lanthanide complexes
06/05/2012US8193173 Liver function ameliorant
06/05/2012US8193172 Administering a steroid
06/05/2012US8193171 13,13-dimethyl-des-C,D analogs of 1α,25-dihydroxy-19-nor-vitamin D3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
06/05/2012US8193170 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
06/05/2012US8193169 (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
06/05/2012US8193168 Use of a TRPM5 inhibitor to regulate insulin and GLP-1 release
06/05/2012US8193167 Pharmacologically active agents containing esterified phosphonates and methods for use thereof
06/05/2012US8193166 Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
06/05/2012US8193165 Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections
06/05/2012US8193164 Organic compounds
06/05/2012US8193159 MCP-1 binding nucleic acids
06/05/2012US8193157 Antiviral therapies
06/05/2012US8193152 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds
06/05/2012US8193151 Methods for treating atrial or ventricular arrhythmias
06/05/2012US8193147 Use of copolymer 1 for treatment of muscular dystrophy
06/05/2012US8192987 Human dental follicle stem cells and methods for obtaining
06/05/2012US8192935 Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression
06/05/2012US8192775 Crystallization of polyol compositions, crystalline polyol composition product and use thereof
06/05/2012US8192769 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
06/05/2012US8192766 Copper-based fungicide/bactericide
06/05/2012US8192762 Preparation of soluble and colloidal molecularly imprinted polymers by living polymerization
06/05/2012US8192756 Gastric retained gabapentin dosage form
06/05/2012US8192755 contains cephalexin or cefaclor, hydroxypropyl methylcellulose, sodium alginate and one xanthan gum
06/05/2012US8192753 pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same
06/05/2012US8192750 Pharmaceutical composition for the treatment of otomycosis
06/05/2012US8192743 Releasable polymeric conjugates based on aliphatic biodegradable linkers
06/05/2012US8192734 Compositions and methods for bone strengthening
06/05/2012US8192732 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
06/05/2012US8192731 Thickened cyanoacrylate compositions
06/05/2012US8192722 Abuse-proof dosage form
06/05/2012US8191802 Aerosol
06/05/2012CA2689438C Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound
06/05/2012CA2681809C Imidazolidinone derivatives
06/05/2012CA2671816C Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same
06/05/2012CA2670236C Therapeutic treatment of androgen receptor driven conditions
06/05/2012CA2664427C Controlled release delivery system for nasal application of neurotransmitters
06/05/2012CA2661861C Heterocyclic fxr binding compounds
06/05/2012CA2596013C Benzoimidazole derivatives and pharmaceutical composition comprising the same
06/05/2012CA2585623C Ortho-substituted benzene derivatives
06/05/2012CA2582984C Novel use of .alpha.-sympathomimetics having a 2-imidazoline structure
06/05/2012CA2571019C 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
06/05/2012CA2562142C Prolonged-release compositions comprising torasemide and a matrix-forming polymer
06/05/2012CA2557275C Bicyclo derivative
06/05/2012CA2540163C Thrombin receptor antagonists
06/05/2012CA2539349C 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/05/2012CA2528667C Reagents for modifying biopharmaceuticals, the use and production thereof
06/05/2012CA2520740C Process for the preparation of amorphous calcium salt of atorvastatin
1 ... 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 ... 7860